The significance of the hemoglobin A2 value in screening for hemoglobinopathies
- 1 December 2009
- journal article
- review article
- Published by Elsevier in Clinical Biochemistry
- Vol. 42 (18) , 1786-1796
Abstract
No abstract availableKeywords
This publication has 123 references indexed in Scilit:
- Frequency of α-Globin Gene Triplications and Their Interaction with β-Thalassemia MutationsHemoglobin, 2009
- A novel mutation of the β‐globin gene promoter (−102 C>A) and pitfalls in family screeningAmerican Journal of Hematology, 2007
- A novel beta‐delta globin gene fusion, anti‐Lepore Hong Kong, leads to overexpression of delta globin chain and a mild thalassaemia intermedia phenotype when co‐inherited with β0‐thalassaemiaBritish Journal of Haematology, 2006
- Molecular, haematological and clinical studies of a silent β‐gene C → G mutation at 6 bp 3′ to the termination codon (+1480 C → G) in twelve Greek familiesBritish Journal of Haematology, 1998
- Genotype of subjects with borderline hemoglobin A2 levels: Implication for, β‐thalassemia carrier screeningAmerican Journal of Hematology, 1994
- Molecular characterization of ?-thalassemia in HungaryHuman Genetics, 1993
- Some properties of hemoglobin A2American Journal of Hematology, 1993
- Heterozygous β‐thalassemia: Relationship between the hematological phenotype and the type of β‐thalassemia mutationAmerican Journal of Hematology, 1992
- β‐Thalassemia in AlgeriaAnnals of the New York Academy of Sciences, 1990
- β‐Thalassemia Mutations in SicilyaAnnals of the New York Academy of Sciences, 1990